Related Experiment Video
Updated: Nov 3, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies
Marjorie Canu1, Léa Margerit1, Ismail Mekhdoul1
1Department of Cardiology, University Hospital, 38000 Grenoble Alpes, France.
Insights
High coronary atherosclerotic burden (CAB) is a significant predictor of major adverse cardiovascular events (MACE) in patients with non-ischemic dilated cardiomyopathy (dCMP). This finding suggests CAB may be a new prognostic factor for dCMP.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Cardiovascular Disease
Background:
- Atherosclerosis is linked to poor outcomes in ischemic cardiomyopathy.
- The prognostic significance of coronary atherosclerotic burden (CAB) in non-ischemic dilated cardiomyopathy (dCMP) is less understood.
Purpose of the Study:
- To investigate the prognostic impact of CAB in patients diagnosed with dCMP.
Main Methods:
- 139 dCMP patients with left ventricular dysfunction underwent invasive coronary angiography and cardiac magnetic resonance (CMR) imaging.
- Coronary atherosclerotic burden (CAB) was quantified using the Gensini score.
- Major adverse cardiovascular events (MACE) were tracked over a median follow-up of 2.8 years.
Main Results:
- Patients experiencing MACE had significantly higher CAB compared to those without events (p < 0.0001).
- Coronary atherosclerotic burden (CAB) independently predicted MACE in multivariate analysis (OR: 1.12, p = 0.02).
Conclusions:
- Elevated coronary atherosclerotic burden (CAB) may serve as a novel prognostic marker in patients with non-ischemic dilated cardiomyopathy (dCMP).
Background:
Atherosclerosis is associated with a worse prognosis in many diseases such as ischemic cardiomyopathy, but its impact in non-ischemic dilated cardiomyopathy (dCMP) is lesser known. Our aim was to study the prognostic impact of coronary atherosclerotic burden (CAB) in patients with dCMP.
Methods:
Consecutive patients with dCMP and left ventricular (LV) dysfunction diagnosed by concomitant analysis of invasive coronary angiography (ICA) and CMR imaging were identified from registry-database. CAB was measured by Gensini score. The primary composite endpoint was the occurrence of major adverse cardiovascular events (MACE) defined as cardiovascular (CV) mortality, non-fatal MI and unplanned myocardial revascularization. The results of 139 patients constituting the prospective study population (mean age 59.4 ± 14.7 years old, 74% male), average LV ejection fraction was 31.1 ± 11.02%, median Gensini score was 0 (0-3), and mid-wall late gadolinium enhancement (LGE) was the most frequent LGE pattern (42%). Over a median follow-up of 2.8 years, 9% of patients presented MACE. Patients with MACE had significantly higher CAB compared to those who were free of events (0 (0-3) vs. 3.75 (2-15), p < 0.0001). CAB remained the significant predictor of MACE on multivariate logistic analysis (OR: 1.12, CI: 1.01-1.23, p = 0.02).
Conclusion:
High CAB may be a new prognostic factor in dCMP patients.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease I: Introduction

